THE DUBERSTEIN GROUP INC. for PHRMA INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Monitor offsets for medical device tax repeal - HR 436, Health Care Cost Reduction Act of 2012.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BERMAN | — |
| STEVEN CHAMPLIN | — |
| KENNETH DUBERSTEIN | — |
| BRIAN GRIFFIN | — |
| DANIEL P MEYER | — |
| MARTI THOMAS | — |
| ERIC UELAND | — |
Health Issues HCR
Implementation of Patient Protection and Affordable Care Act, including monitoring and assessing Congresisonal response - Proposed legislation re these issues; Executive Branch actions re these issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BERMAN | — |
| STEVEN CHAMPLIN | — |
| KENNETH DUBERSTEIN | — |
| BRIAN GRIFFIN | — |
| DANIEL P MEYER | — |
| MARTI THOMAS | — |
| ERIC UELAND | — |
Pharmacy PHA
Pharmaceutical issues, including fostering competition between generic and brand-name pharmaceutical manufacturers; FDA User Fee agreements - HR 5651, Food and Drug Administration Reform Act of 2012; S 3187, Food and Drug Administration Safety and Innovation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BERMAN | — |
| STEVEN CHAMPLIN | — |
| KENNETH DUBERSTEIN | — |
| BRIAN GRIFFIN | — |
| DANIEL P MEYER | — |
| MARTI THOMAS | — |
| ERIC UELAND | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.